By Abigail Rubenstein ( June 1, 2015, 11:30 AM EDT) -- Chinese biotechnology company 3SBio, which was taken private by its CEO and a private equity firm in 2013, said Monday that it will seek up to HK$5.51 billion ($710.45 million) through an initial public offering on the Hong Kong Stock Exchange to expand its pharmaceutical product offerings through acquisitions....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.